172 related articles for article (PubMed ID: 37403944)
1. IgG4-related pachymeningitis-Long term follow up and outcome of six patients.
Yardimci GK; Arslan D; Babaoğlu B; Bolek EC; Kilic L; Saglam A; Tuncer A; Söylemezoğlu F; Gocmen R; Oguz KK; Tan E; Karadag O
Int J Rheum Dis; 2023 Sep; 26(9):1853-1860. PubMed ID: 37403944
[TBL] [Abstract][Full Text] [Related]
2. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.
Sergio P; Alejandro R; Cristian F
Reumatol Clin (Engl Ed); 2023; 19(6):338-344. PubMed ID: 37179159
[TBL] [Abstract][Full Text] [Related]
4. Refractory IgG4-related disease complicated with organising pneumonia and hypertrophic pachymeningitis.
Abe F; Michishita Y; Saito M; Nara M; Wakui H; Takahashi N
Mod Rheumatol Case Rep; 2022 Jun; 6(2):278-281. PubMed ID: 35355069
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal rituximab for IgG
Della-Torre E; Campochiaro C; Cassione EB; Albano L; Gerevini S; Bianchi-Marzoli S; Bozzolo E; Passerini G; Lanzillotta M; Terreni M; Callea M; Trimarchi M; Mortini P; Tresoldi M; Acerno S; Dagna L
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):441-444. PubMed ID: 28819060
[No Abstract] [Full Text] [Related]
7. Immunoglobulin G4-related spinal pachymeningitis.
Alrashdi MN
Saudi Med J; 2020 Jun; 41(6):652-656. PubMed ID: 32518934
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related uveitis. A French cohort and literature review.
Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of central nervous system involvement in IgG4 related diseases].
Meng GY; Zhang YX; Zhang YX; Liu YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1043-1048. PubMed ID: 34916679
[TBL] [Abstract][Full Text] [Related]
10. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
Tanboon J; Felicella MM; Bilbao J; Mainprize T; Perry A
Clin Neuropathol; 2013; 32(4):291-7. PubMed ID: 23320997
[TBL] [Abstract][Full Text] [Related]
11. Pachymeningitis in Biopsy-Proven Sarcoidosis: Clinical Course, Radiographic Findings, Response to Treatment, and Long-term Outcomes.
Chakales PA; Herman MC; Chien LC; Hutto SK
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36163175
[TBL] [Abstract][Full Text] [Related]
12. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
13. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
14. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
Gospodarev V; Câmara J; Chakravarthy V; Perry A; Wood M; Dietz R; Wang J; De Los Reyes K; Raghavan R
J Neuroimmunol; 2016 Oct; 299():62-65. PubMed ID: 27725123
[TBL] [Abstract][Full Text] [Related]
15. Clinical Perspectives on IgG4-Related Disease and Its Classification.
Katz G; Stone JH
Annu Rev Med; 2022 Jan; 73():545-562. PubMed ID: 34669430
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G4-related disease: case report and literature review.
Dong LL; Sheikh IS; Huang AH; Wu XH; Chen EG; Ying KJ
Immunol Res; 2021 Oct; 69(5):415-421. PubMed ID: 34374950
[TBL] [Abstract][Full Text] [Related]
17. The neurology of IGG4-related disease.
Saitakis G; Chwalisz BK
J Neurol Sci; 2021 May; 424():117420. PubMed ID: 33845982
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
19. IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report.
Nilles C; Poillon G; Deschamps L; Daval M; Diallo IM; Deschamps R; Boudot de la Motte M
J Neuroimmunol; 2021 Nov; 360():577717. PubMed ID: 34517153
[TBL] [Abstract][Full Text] [Related]
20. [A Case of IgG4-related Hypertrophic Pachymeningitis].
Hayashi K; Somagawa C; Hayashi Y; Iwanaga M
No Shinkei Geka; 2018 Dec; 46(12):1103-1109. PubMed ID: 30572308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
